Experimental drug treatment of scrapie: A pathogenetic basis for rationale therapeutics

M. Pocchiari, M. Salvatore, A. Ladogana, L. Ingrosso, Y. G. Xi, M. Cibati, C. Masullo

Research output: Contribution to journalArticlepeer-review

10 Scopus citations

Abstract

Pharmacological treatment with polyanions or amphotericin B in hamsters with experimental scrapie reveals that it is possible to delay the appearance of the disease only when the drug is given before the invasion of the agent into the clinical target areas of the brain. We suggest such early treatment may be possible for individuals at high risk of acquiring the disease, such as healthy mutation-positive relatives of patients with familial Creutzfeldt-Jakob disease or Gerstmann-Sträussler syndrome, or recipients of potentially contaminated pituitary-extracted human growth hormone.

Original languageEnglish
Pages (from-to)556-561
Number of pages6
JournalEuropean Journal of Epidemiology
Volume7
Issue number5
DOIs
StatePublished - Sep 1991
Externally publishedYes

Keywords

  • Amphotericin B
  • Creutzfeldt-Jakob disease
  • Pathogenesis
  • Scrapie
  • Sulphate Polyanions
  • Therapy

Fingerprint

Dive into the research topics of 'Experimental drug treatment of scrapie: A pathogenetic basis for rationale therapeutics'. Together they form a unique fingerprint.

Cite this